Home/Pipeline/Re-Clinic

Re-Clinic

Not specified (likely a platform/service development project)

N/A (Service/Platform Development)Active

Key Facts

Indication
Not specified (likely a platform/service development project)
Phase
N/A (Service/Platform Development)
Status
Active
Company

About Probiomics

Probiomics is a Milan-based, private biotechnology service provider that operates at the intersection of experimental omics assays and advanced bioinformatics. Leveraging technologies from partners like Olink, Oxford Nanopore, and Fluidigm, the company offers a comprehensive suite of services for generating and analyzing genomic, transcriptomic, proteomic, and epigenetic data. Its core value proposition is the integration of multiple omics layers to provide clients with a holistic view of biological systems, supported by a proprietary web platform and a multidisciplinary team. The company appears to be in an early-revenue stage, serving research clients and developing its 'Re-Clinic' project with regional grant support.

View full company profile